Fig. 1From: ELQ-331 as a prototype for extremely durable chemoprotection against malariaSummary of Trial 1 protocol and results. The timepoints for blood stage challenges, blood sampling for snapshot pharmacokinetic analysis, and sporozoite challenges are noted on the x-axis. The outcomes of efficacy trials are represented graphically as red = no protection and green = complete protection, and the proportion of challenged mice with each outcome is noted. The table insert summarizes the results of snapshot PK at the indicated timepointsBack to article page